TABLE 2.
In-hospital evolution of the entire cohort and according to the presence of abnormal RBC morphologies.
| Entire cohort | Abnormal RBC morphologies | ||||
|---|---|---|---|---|---|
| No (n = 40) | <10% (n = 44) | >10% (n = 31) | p-value | ||
| Evolution | |||||
| Length of hospitalization (days) | 13 [9–21] | 10 [8–18] | 14 [10–28] | 14 [9–22] | 0.123 |
| ARDS | 5 (4.3) | 1 (2.5) | 1 (2.3) | 3 (9.7) | 0.309 |
| Need for RBCs transfusion | 12 (10.4) | 3 (7.5) | 4 (9.1) | 5 (16.1) | 0.483 |
| Maximal O2 therapy needed | |||||
| No O2 therapy needed | 13 (11.3) | 5 (12.5) | 8 (18.2) | 0 | |
| Standard O2 therapy a | 71 (61.7) | 29 (72.5) | 22 (50.0) | 20 (64.5) | |
| Ventilation/Intubation b | 31 (27.0) | 6 (15.0) | 14 (31.8) | 11 (35.5) | |
| ICU admission | 16 (13.9) | 1 (2.5) | 9 (20.5) | 6 (19.4) | 0.021 |
| In-hospital death | 27 (23.5) | 5 (12.5) | 9 (20.5) | 13 (41.9) | 0.012 |
Data are presented as n (%) or median [interquartile range]. Statistical significance was set at p < 0.05. p values < 0.05 are indicated in bold.
ARDS, acute respiratory distress syndrome; RBCs, red blood cells; ICU, intensive care unit.
a
Oxygen delivered through nasal cannula, Venturi mask or reservoir mask.
b
Non-invasive ventilatory support or orotracheal intubation.